Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Conmed reported earnings of $0.79 per share, beating estimates by 6.76%. - Revenues for the quarter ended March 2024 were $312.27 million, surpassing estimates by 1.70%. - Conmed shares have lost about 34.9% since the beginning of the year. - Management's commentary on earnings call will impact stock's immediate movement. - Estimate revisions for Conmed are mixed, currently a Zacks Rank #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Conmed reported earnings of $0.79 per share, beating estimates by 6.76%.
- Revenues for the quarter ended March 2024 were $312.27 million, surpassing estimates by 1.70%.
- Conmed shares have lost about 34.9% since the beginning of the year.
- Management's commentary on earnings call will impact stock's immediate movement.
- Estimate revisions for Conmed are mixed, currently a Zacks Rank #3 (Hold).
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.